Home > Insider Trading > Filing (0001093557-20-000037)

Filing Details

Accession Number:: 0001093557-20-000037
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2020-02-20 18:23:10
Reporting Period:: 2020-02-18

Accepted Time:: 2020-02-20 18:23:10
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1093557	Dexcom Inc	DXCM	Surgical & Medical Instruments & Apparatus (3841)	330857544

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1446422	Jeffrey Moy	6340 Sequence Drive San Diego CA 92121	Evp Operations	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2019-09-11	4,461	$0.00	30,408	No	5	J	Direct
Common Stock	Acquisiton	2019-09-11	4,461	$0.00	31,819	No	5	J	Indirect	by Trust
Common Stock	Disposition	2020-02-18	610	$283.37	31,209	No	4	S	Indirect	by Trust
Common Stock	Disposition	2020-02-18	1,694	$284.23	29,515	No	4	S	Indirect	by Trust
Common Stock	Disposition	2020-02-18	800	$286.55	28,715	No	4	S	Indirect	by Trust
Common Stock	Disposition	2020-02-18	400	$287.41	28,315	No	4	S	Indirect	by Trust
Common Stock	Disposition	2020-02-18	2,795	$288.99	25,520	No	4	S	Indirect	by Trust
Common Stock	Disposition	2020-02-18	200	$289.84	25,320	No	4	S	Indirect	by Trust
Common Stock	Disposition	2020-02-18	100	$290.98	25,220	No	4	S	Indirect	by Trust

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	5	J	Direct
No	5	J	Indirect	by Trust
No	4	S	Indirect	by Trust
No	4	S	Indirect	by Trust
No	4	S	Indirect	by Trust
No	4	S	Indirect	by Trust
No	4	S	Indirect	by Trust
No	4	S	Indirect	by Trust
No	4	S	Indirect	by Trust

Footnotes

Shares were transferred from direct ownership to ownership under the Moy Family Trust upon vesting of previously awarded restricted stock units.
Included in this number are 30,408 unvested restricted stock units, 11,714 of which were granted on March 8, 2019 and shall vest through March 8, 2022, 15,047 of which were granted on March 8, 2018 and shall vest through March 8, 2021 and 3,647 of which were granted on March 8, 2017 and shall vest through March 8, 2020.
Shares are held by the Moy Family Trust U/A/D 12/09/2013, with respect to which the reporting person is a trustee.
On November 20, 2019, Mr. Moy adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Moy. The shares set forth above were sold pursuant to the 10b5-1 Plan.
This transaction was executed in multiple trades at prices ranging from $282.99 to $283.81. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.
This transaction was executed in multiple trades at prices ranging from $283.99 to $284.44. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.
This transaction was executed in multiple trades at prices ranging from $286.03 to $287.00. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.
This transaction was executed in multiple trades at prices ranging from $287.39 to $287.42. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.
This transaction was executed in multiple trades at prices ranging from $288.71 to $289.70. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.